Although baseline clinical characteristics and angiographic features were quite homogenously distributed in patients with and without ISR, certain selection biases and unknown confounding factors possibly impacting IgE and CML could not be excluded. The gene discussed is IGHE; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.